1 이중서, "한국판 Hamilton 우울증 평가 척도의 신뢰도, 타당도 연구" 대한신경정신의학회 44 (44): 456-465, 2005
2 박준혁, "한국의 우울증 역학에 대한 고찰" 대한의사협회 54 (54): 362-369, 2011
3 고영훈, "정신병적 우울증의 특성과 치료" 대한정신약물학회 16 (16): 341-350, 2005
4 Carroll BJ, "Urinary free cortisol excretion in depression" 6 : 43-50, 1976
5 Young EA, "Twenty-four-hour ACTH and cortisol pulsatility indepressed women" 25 : 267-276, 2001
6 DeLeo JA, "The role of neuroinflammation and neuroimmune activation in persistent pain" 90 : 1-6, 2001
7 Kong WM, "The midnight to morning urinary cortisol increment is an accurate,noninvasive method for assessment of the hypothalamicpituitry-adrenal axis" 84 : 3093-3098, 1999
8 Nemeroff CB, "The corticotropin-releasing factor(CRF)hypothesis of depression:new findings and new directions" 1 : 336-342, 1996
9 Jadwiga Piwowarska, "Serum Cortisol concentration in patients with major depression after treatment with clomipramine" 61 : 604-611, 2009
10 Gold PW, "Psychiatric implications of basic and clinical studies with corticotrophin-releasing factors" 141 : 619-627, 1984
1 이중서, "한국판 Hamilton 우울증 평가 척도의 신뢰도, 타당도 연구" 대한신경정신의학회 44 (44): 456-465, 2005
2 박준혁, "한국의 우울증 역학에 대한 고찰" 대한의사협회 54 (54): 362-369, 2011
3 고영훈, "정신병적 우울증의 특성과 치료" 대한정신약물학회 16 (16): 341-350, 2005
4 Carroll BJ, "Urinary free cortisol excretion in depression" 6 : 43-50, 1976
5 Young EA, "Twenty-four-hour ACTH and cortisol pulsatility indepressed women" 25 : 267-276, 2001
6 DeLeo JA, "The role of neuroinflammation and neuroimmune activation in persistent pain" 90 : 1-6, 2001
7 Kong WM, "The midnight to morning urinary cortisol increment is an accurate,noninvasive method for assessment of the hypothalamicpituitry-adrenal axis" 84 : 3093-3098, 1999
8 Nemeroff CB, "The corticotropin-releasing factor(CRF)hypothesis of depression:new findings and new directions" 1 : 336-342, 1996
9 Jadwiga Piwowarska, "Serum Cortisol concentration in patients with major depression after treatment with clomipramine" 61 : 604-611, 2009
10 Gold PW, "Psychiatric implications of basic and clinical studies with corticotrophin-releasing factors" 141 : 619-627, 1984
11 Hummel M, "Pain is a salient"stressor"that is mediated by corticotrophin-releasing factor-1 receptors" 59 : 160-166, 2010
12 Jaferi A, "Mu-opioid and corticotrophin-releasing-factor receptors show largely postsynaptic co-expression,and separate presynaptic distribution,in the mouse central amygdale and bed nucleus of the stria terminalis" 59 : 526-539, 2009
13 Cornelius Schule, "Hypothalamic-pituitary-adrenocortical system dysregulation and new treatment strategies" 9 : 1005-1019, 2009
14 Watkins LR, "Glial activation:a driving force for pathological pain" 24 : 450-455, 2001
15 Marcos T, "Factor study of the Hamilton Rating Scale for Depression and the Bech Melancholia Scale" 82 : 178-181, 1990
16 Young EA, "Disordered adrenocorticotropin secretion in women with major depression" 91 : 1924-1928, 2006
17 Connor TJ, "Depression,stress and immunological activation:the role of cytokines in depressive disorders" 62 : 583-606, 1998
18 Burke HM, "Depression and cortisol responses to psychological stress; A meta-analysis" 30 : 846-856, 2005
19 Webster EL, "Corticotropin-releasing hormone and inflammation" 840 : 21-32, 1998
20 Myers DA, "Corticosterone implants to the amygdala and type 1 CRH receptor regulation:effects on behavior and colonic sensitivity" 161 : 39-44, 2005
21 Martinez V, "CRF 1 receptors as a therapeutic target for irritable bowel syndrome" 12 : 4071-4088, 2006
22 Schulkin J, "Allostasis,amygdala,and anticipatory angst" 18 : 385-396, 1994
23 Nemeroff CB, "Adrenal gland enlargement in major depression.A Computed tomographic study" 49 : 384-387, 1992
24 Stern N, "Adrenal Testing" The Endocrine Society 263-264, 1999